Semaglutide, the key ingredient of Wegovy and Ozempic known for their weight loss properties went off-patent on Friday, triggering a flood of affordably-priced generic variants from Indian manufacturers. However, the DGCI sees cause for concern, and has alert…
The Drugs Controller General of India (DCGI) has asked states to ensure that endocrinologists - specialists in hormones and endocrine glands - alone can prescribe these medicines, two officials aware… [+5501 chars]
